Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Argentina, Australia, Bulgaria, Canada +24 more
Sponsor: Pierre Fabre Medicament
BRAF V600E-mutant Metastatic Colorectal Cancer
United States, Austria, Belgium, France, Italy +4 more
- A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal AdenocarcinomaActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Tumor · Adenocarcinoma
United States
- Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Hepatic Insufficiency
Sponsor: Jonsson Comprehensive Cancer Center
Renal Pelvis and Ureter Urothelial Carcinoma
United States
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Chronic Lymphocytic Leukaemia · Small Lymphocytic Lymphoma · Hematologic Malignancies
Sponsor: Merck Sharp & Dohme LLC
Advanced or Metastatic Solid Tumors
United States, Canada, Switzerland
- A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Diabetic Retinopathy · Macular Edema
- A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)Not Yet Recruiting
Sponsor: Merck Sharp & Dohme LLC
Diabetic Retinopathy · Macular Edema
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
- Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not Yet Recruiting
Sponsor: National Cancer Centre, Singapore
Recurrent Adenoid Cystic Carcinoma · Adenoid Cystic Carcinoma Metastatic · Papillary Thyroid Carcinoma
Japan, Malaysia, Singapore, South Korea
Sponsor: Coherus Oncology, Inc.
Advanced Solid Tumor · Clear Cell Renal Cell Carcinoma · Hepatocellular Carcinoma · Non-small Cell Lung Cancer
United States, Singapore, South Korea
- Letermovir for R+ StudyNot Yet Recruiting
Sponsor: University of Wisconsin, Madison
Kidney Transplant · Liver Transplant
United States
- Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Breast Cancer
United States, Argentina, Australia, Austria, Belgium +19 more
Sponsor: Hospital Universitario San Ignacio
Lung Cancer
Colombia
Sponsor: Daiichi Sankyo
Hormone Receptor Positive · HER2-low or HER2-ultralow · Unresectable or Metastatic Breast Cancer
- Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Active Not Recruiting
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification · Lung Adenocarcinoma Stage IIIB/IV
United States, Austria, Belgium, China, France +10 more
Sponsor: Zin W Myint
Prostate Cancer
United States
- A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsActive Not Recruiting
Sponsor: IDEAYA Biosciences
Advanced or Metastatic Solid Tumors · Breast Cancer · Ovarian Cancer · Prostate Cancer
United States
- A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Renal Cell Carcinoma
United States, Argentina, Australia, Canada, Chile +9 more
Sponsor: University of Minnesota
Sleep · Alzheimer Disease
United States
- Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Metastatic Castration-Resistant Prostate Cancer
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm · Carcinoma, Merkel Cell · Lymphoma
Japan
Sponsor: Boston Medical Center
Vaccine Hesitancy · Vaccine Refusal
United States
- Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)Active Not Recruiting
Sponsor: Laura M. Spring, MD
Triple Negative Breast Cancer · Hormone Receptor Positive (HR+), HER2-negative Breast Cancer · Biopsy-proven, Positive Lymph Node(s)
United States